0000950123-18-011520.txt : 20181114
0000950123-18-011520.hdr.sgml : 20181114
20181114064257
ACCESSION NUMBER: 0000950123-18-011520
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20180930
FILED AS OF DATE: 20181114
DATE AS OF CHANGE: 20181114
EFFECTIVENESS DATE: 20181114
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bain Capital Life Sciences Investors, LLC
CENTRAL INDEX KEY: 0001703031
IRS NUMBER: 813996001
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-18477
FILM NUMBER: 181180309
BUSINESS ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 6175162878
MAIL ADDRESS:
STREET 1: 200 CLARENDON STREET
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
13F-HR
LIVE
false
true
false
0001703031
XXXXXXXX
09-30-2018
09-30-2018
Bain Capital Life Sciences Investors, LLC
200 Clarendon Street
BOSTON
MA
02116
13F HOLDINGS REPORT
028-18477
Y
Bain Capital Life Sciences Investors, LLC is the general partner of Bain Capital Life Sciences Partners, LP, which is the general partner of Bain Capital Life Sciences Fund, L.P.
Adam Koppel
Managing Dir. of Bain Capital Life Sciences Investors, LLC
(617) 516-2000
/s/ Adam Koppel
Boston
MA
11-14-2018
2
6
440629
false
1
28-18476
Bain Capital Life Sciences Partners, LP
2
28-18478
Bain Capital Life Sciences Fund, L.P.
INFORMATION TABLE
2
form13fInfoTable.xml
INFORMATION TABLE FOR FORM 13F
DICERNA PHARMACEUTICALS INC
COM
253031108
136275
8930237
SH
SOLE
8930237
0
0
MARINUS PHARMACEUTICALS INC
COM
56854Q101
39775
3977453
SH
SOLE
3977453
0
0
INFLARX NV
COM
N44821101
60571
1764888
SH
SOLE
1764888
0
0
SOLID BIOSCIENCES INC
COM
83422E105
93862
1989444
SH
SOLE
1989444
0
0
APTINYX INC
COM
03836N103
64439
2225092
SH
SOLE
2225092
0
0
REPLIMUNE GROUP INC
COM
76029N106
45707
2838968
SH
SOLE
2838968
0
0